“…This assay has outstanding features: (1) it can be performed in a mix-and-read manner within 10 min, which is the rapidest and simplest method reported so far for the lncRNA MALAT1 assay; (2) this assay can be performed in an absolutely isothermal condition (50 °C), eliminating the requirement for a sophisticated thermal cycler and precise temperature control in a conventional PCR assay; (3) high amplification efficiency of multiple cyclic ERA and high cleavage efficiency of APE1-assisted cyclic catalysis endow this assay with improved sensitivity; (4) this assay can be extended to detect any nucleic acids without considering the length of targets. In comparison with the previously reported methods (Table S1), this assay has the advantages of rapidity (within 10 min), lower LOD (0.87 aM), and good performance in clinical samples. ,,− Moreover, the proposed assay can accurately measure cellular lncRNA MALAT1 at the single-cell level and even discriminate the lncRNA expression level between breast cancer tissues and their corresponding healthy adjacent tissues. Importantly, this assay can be easily reconfigured to detect a series of RNAs (e.g., miRNA, circRNA, mRNA, and SARS-CoV-2 RNA) by just changing the recognition sequences, and it can be integrated with many signal amplification approaches (e.g., ELOSA, SDA, and RCA) , to sensitively detect RNAs and other targets (e.g., DNAs, proteins, and small molecules), providing a promising platform for biomedical research, clinical diagnostics, and therapeutics.…”